Aspects of primary and secondary prevention of heart failure in patients with asthma
https://doi.org/10.15829/3034-4123-2025-35
EDN: HDTAJS
Abstract
The modern concept of a personalized approach to studying the relationship between diseases contributes to an in-depth multimorbidity study. Asthma is one of the most common pathologies among chronic respiratory diseases, characterized by wide heterogeneity and high comorbidity, especially with cardiovascular diseases in the older age group. Due to the difficulties of differential diagnosis of these diseases and their mutually aggravated course, measures for the prevention of heart failure (HF) in asthma patients should be structured.
The aim of the review was to highlight the etiology, similarity of the clinical performance and common pathogenesis links in patients with HF and asthma, as well as the main approaches to the prevention of heart failure in patients with asthma.
The review summarizes recommendations for the prevention of HF and outpatient follow-up of asthma patients for the timely diagnosis of HF.
About the Authors
M. B. Savich
https://prmed.elpub.ru/jour/user/register
Voyno-Yasenetsky Krasnoyarsk State Medical University ; Regional Clinical Hospital
Russian Federation
Voyno-Yasenetsky Krasnoyarsk State Medical University ; Regional Clinical Hospital
Russian Federation
Krasnoyarsk
I. V. Demko
Voyno-Yasenetsky Krasnoyarsk State Medical University ; Regional Clinical Hospital
Russian Federation
Russian Federation
Krasnoyarsk
E. A. Sobko
Voyno-Yasenetsky Krasnoyarsk State Medical University ; Regional Clinical Hospital
Russian Federation
Russian Federation
Krasnoyarsk
O. P. Ishchenko
Voyno-Yasenetsky Krasnoyarsk State Medical University ; Regional Clinical Hospital
Russian Federation
Russian Federation
Krasnoyarsk
References
1. Oganov RG, Simanenkov VI, Bakulin IG, et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5-66. (In Russ.) doi:10.15829/1728-8800-2019-1-5-66.
2. Chuchalin AG, Khaltaev N, Antonov NS, et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014;9:963-74. doi:10.2147/COPD.S67283.
3. Kraposhina AYu, Sobko EA, Demko IV, et al. Difficult-to-treat asthma: the most significant factors impeding control. Bulletin Physiology and Pathology of Respiration. 2024;(91):23-33. (In Russ.) doi:10.36604/1998-5029-2024-91-23-33.
4. Kraposhina AYu, Sobko EA, Demko IV, et al. Modern Understanding of Severe Bronchial Asthma. The Russian Archives of Internal Medicine. 2022;12(2):113-22. (In Russ.) doi:10.20514/2226-6704-2021-12-2-113-122.
5. Ushakova DV, Nikonov EL. The problem of comorbidity in patients with asthma. Lechashchij vrach. 2018;12:65-8. (In Russ.)
6. Ostroumova OD, Goloborodova IV, Voevodina NYu, et al. Asthma and cardiovascular disease. Consilium Medicum. 2018;20(5):8-16. (In Russ.) doi:10.26442/2075-1753_2018.5.8-16.
7. Galyavich AS, Tereshchenko SN, Uskach TM, Ageev FT. 2024 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2024; 29(11):6162. (In Russ.) doi:10.15829/1560-4071-2024-6162. EDN: WKIDLJ.
8. Chen J, Aronowitz P. Congestive Heart Failure. Med Clin North Am. 2022;106(3): 447-58. doi:10.1016/j.mcna.2021.12.002.
9. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263-e421. doi:10.1016/j.jacc.2021.12.012.
10. Lawson CA, Zaccardi F, Squire I, et al. Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity. Circulation. Heart Fail. 2020;13(2):e006472. doi:10.1161/CIRCHEARTFAILURE.119.006472.
11. Timofeev YuS, Afaunova AR, Metelskaya VA, et al. Heat shock proteins as potential biomarkers of heart failure. Cardiovascular Therapy and Prevention. 2024;23(4):3938. (In Russ.) doi:10.15829/1728-8800-2024-3938.
12. Schwinger RHG. Pathophysiology of heart failure. Cardiovasc Diagn Ther. 2021;11(1):263-76. doi:10.21037/cdt-20-302.
13. Alvarado AC, Pinsky MR. Cardiopulmonary interactions in left heart failure. Front Physiol. 2023;14:1237741. doi:10.3389/fphys.2023.1237741.
14. Uryas’ev OM. Bronchial asthma and cardiovascular diseases. Zemskij vrach. 2015;4(28):5-14. (In Russ.)
15. Thandavarayan RA, Chitturi KR, Guha A. Pathophysiology of Acute and Chronic Right Heart Failure. Cardiol Clin. 2020;38(2):149-60. doi:10.1016/j.ccl.2020.01.009.
16. Mincewicz G, Siergiejko G, Piepiorka M, et al. Functional assessment of the right ventricle in patients with bronchial asthma of various severity. Postep Derm Alergol. 2021;38(2):52-6. doi:10.5114/ada.2021.104278.
17. Caplan M, Hamzaoui O. Cardio-respiratory interactions in acute asthma. Front Physiol. 2023;14:1232345. doi:10.3389/fphys.2023.1232345.
18. Martynenko ТI, Paraeva OS, Dronov SV, et al. Improvement in early differentiation of breathlessness due to pulmonary or cardiac disease. Pulmonology. 2014;(1):27- 31. (In Russ.) doi:10.18093/0869-0189-2014-0-1-27-31.
19. Vertkin AL, Topolyansky AV, Knorring GYu, et al. Management of a patient with dyspnea on an outpatient admission. Consilium Medicum. 2019;21(1):98-104. (In Russ.) doi:10.26442/20751753.2019.1.190279.
20. Shtegman OA, Petrova MM, Virva PV. Genesis of dyspnea in ambulatory patients with suspected to the chronic heart failure. Siberian Medical Review. 2013:82(4):63-6. (In Russ.)
21. Shlyakhto EV. Classification of heart failure: focus on prevention. Editorial. Russian Journal of Cardiology. 2023;28(1):5351. (In Russ.) doi:10.15829/1560-4071-2023-5351.
22. Reddy YNV, Carter RE, Obokata M, et al. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018;138(9):861-70. doi:10.1161/CIRCULATIONAHA.118.034646.
23. Pieske B, TschÖpe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020;22(3):391-412. doi:10.1002/ejhf.1741.
24. Skudarnov EV, Lobanov YuF, Strozenko LA, et. al. Clinical aspects and risk factors of arterial hypo- and hypertension in first year medical students. Bulletin of Medical Science. 2024;1(33):52-61. (In Russ.) doi:10.31684/25418475-2024-1-52.
25. Khvatova YuG, Chernyshev AV. Risk factors and prevention of coronary heart disease. Tambov Medical Journal. 2024;6(2):92-107. (In Russ.) doi:10.20310/2782-5019-2024-6-2-92-107.
26. Kilessa VV, Shkadova MG, Itskova EA, et al. Treatment-resistant chronic heart failure and aspects of its prevention. Krymskij terapevticheskij zhurnal. 2022;3:26- 9. (In Russ.)
27. Unagaeva EA. Chronic obstructive pulmonary disease and cardiovascular diseases: what does GOLD claim? ZHurnal estestvennonauchnyh issledovanij. 2023;3:35- 40. (In Russ.)
28. Smirnova MI, Kurekhyan AS, Gorbunov VM, et al. Prospective followup of hypertensive patients with concomitant chronic respiratory diseases in routine practice. Part I. Characterization of adverse events. Cardiovascular Therapy and Prevention. 2022;21(10):3383. (In Russ.) doi:10.15829/1728-8800-2022-3383.
Supplementary files
Review
For citations:
Savich MB, Demko IV, Sobko EA, Ishchenko OP. Aspects of primary and secondary prevention of heart failure in patients with asthma. Primary Health Care (Russian Federation). 2025;2(1):32-40. (In Russ.) https://doi.org/10.15829/3034-4123-2025-35. EDN: HDTAJS
Views:
115
Email this article 